LION bioscience (Nasdaq: LEON) today announced the formation of its new Supervisory Board. In accordance with ss. 104 (1) of the German Stock Corporation Act (AktG), decided November 3, 2004, the local court in Heidelberg, Germany appointed Dr. Friedrich von Bohlen, Dr. Christoph Mutter and Dr. Jan Traenckner as new members of the Supervisory Board. Dr. Friedrich von Bohlen has been elected Chairman by the new Supervisory Board. Dr. Traenckner has been elected Deputy Chairman and Dr. Mutter Chairman of the Audit Committee. The judiciary appointments are confined and to be reconfirmed by the LION shareholders' vote at the next Annual General Meeting.
